<Record>
<Term>Mofarotene</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Retinoic Acid Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Cell Differentiating Agent/Differentiation Inducer/Retinoic Acid Agent/Mofarotene</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Cell Differentiating Agent</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Mofarotene</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Differentiation Inducer</BroaderTerm>
<BroaderTerm>Retinoic Acid Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>(E)-4-[2-[4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]phenoxy]ethyl]morpholine</Synonym>
<Synonym>Mofarontene</Synonym>
<Synonym>Mofarotene</Synonym>
<Synonym>Ro 40-8757</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
